Cargando…
Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan()
The Japanese regulatory framework for pharmaceuticals and medical devices has recently been reexamined and the revised Pharmaceutical Affairs Law, which has been renamed the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act, was developed in 2013 and implemented in November 2014. I...
Autores principales: | Okada, Kiyoshi, Koike, Kazuhisa, Sawa, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581820/ https://www.ncbi.nlm.nih.gov/pubmed/31245444 http://dx.doi.org/10.1016/j.reth.2015.04.001 |
Ejemplares similares
-
Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()
por: Handa, Nobuhiro, et al.
Publicado: (2015) -
A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of human embryonic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015) -
A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015) -
A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015) -
Leveraging Devices, Data and Discovery for Smarter Healthcare in Japan
por: Sawa, Tomohiro
Publicado: (2011)